US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Market Research Reports & Industry Analysis

In industries from agriculture to environmental science, biotechnology plays an important role in improving industry standards, services, and developing new products. Biotechnology involves the spectrum of life science-based research companies working on transformative technologies for a wide range of industries.

While agriculture, material science and environmental science are major areas of research, the largest impact is made in the field medicine.

As a large player in the research and development of pharmaceuticals, the role of biotechnology in the healthcare field is undeniable. From genetical analysis and manipulation to the formation of new drugs, many biotech firms are transforming into pharmaceutical and biopharmaceutical leaders.

This research category includes various comprehensive reports on research methods, biotech companies, tools, technologies, and equipment commonly used in the biotech industry. You will also find business reports covering funding, product pipelines, mergers and acquisitions, and strategies for development. The “green” and “white” biotech sectors are also covered in the reports herein.

RSS Feeds

Biotechnology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Proteomics Research Markets: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends
5/13/2015 | published by: Kalorama Information
... spend tens of billions of dollars on translational research, which has increased the focus on instruments capable of powerfully assaying and identifying proteins implicated in disease pathways. The Proteomic Research Market Opportunity, Defined Report analyst ...  |  read more...
USD 4,200
Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019
5/14/2015 | published by: MarketsandMarkets
... market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, ...  |  read more...
USD 4,650
North America Spine Surgery Devices Market by Product (Non-Fusion Implants, Spinal Fusion and Fixation Devices, Spine Biologics, Spine Bone Stimulators, VCFT Devices), by End User (Hospitals, Orthopedic Clinics), by Geography - Analysis and Forecast to 20
5/11/2015 | published by: MicroMarketMonitor
... market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the ...  |  read more...
USD 2,650
Feed Enzymes Market by Type (Phytase, Protease, and Non-starch Polysaccharides (Xylanase, ß-glucanase, Cellulase, Mannanase & Pectinase)), Livestock (Swine, Poultry, Ruminants, and Aquatic Animals) & by Region - Global Trends & Forecast to 2020
5/11/2015 | published by: MarketsandMarkets
... enzymes accelerate the biochemical reactions in animals in order to support life. These enzymes are added to the feed of pig, poultry, cattle, and aquatic animals to enhance production efficiency. The major function of feed ...  |  read more...
USD 4,650
Novartis South Africa (Pty) Ltd in Consumer Health (South Africa)
5/11/2015 | published by: Euromonitor International
... continually look for merger and acquisition opportunities internationally to further extend its reach across geographies. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover ...  |  read more...
USD 572
Anti-CD19 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD19 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD19 Antibody- ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD274 (PD-L1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD28 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD28 Antibody- ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD3 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD3 Antibody- ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD30 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD30 Antibody- ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD37 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD37 Antibody- ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD4 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD4 Antibody- ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD40 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD40 Antibody- ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD6 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD6 Antibody- ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD70 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD70 Antibody- ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CS1 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CS1 Antibody- ...  |  read more...
USD 1,250
Research and Development in Biotechnology - The 2015 U.S. Market Research Report
6/1/2015 | published by: Kentley Insights
... Market Research Reports are based on billions of data points created from millions of annual comprehensive business surveys. Used for a range of strategic purposes, from due diligence to streamlining to forecasting to gap analysis ...  |  read more...
USD 195
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-Dickkopf-1 (Dkk-1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aurora A Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Protein (FAP or Seprase) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Activation Protein (FAP or Seprase) Inhibitors Report helps ...  |  read more...
USD 1,250
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (FGF-1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor 1 (FGF-1) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 2 (FGFR2) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors Report helps ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 3 (FGFR3) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors Report helps ...  |  read more...
USD 1,250
G-Protein Coupled Receptor (GPCR) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The G-Protein Coupled Receptor (GPCR) Agonists Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Market Access Excellence for Emerging Markets
5/15/2015 | published by: FirstWord
... Access Excellence for Emerging Markets analyses the pricing and market access issues you must understand now in critical, high-growth markets around the globe. Gain insights on the ever-shifting payer landscape and be better prepared to ...  |  read more...
USD 2,100
< prev 1    3  4  5  6  7  8  9  10